You have read all your free articles, to continue reading subscribe to read the rest of this content.
Evaxion Biotech has announced preclinical data demonstrating the effectiveness of its AI-driven viral vaccine discovery platform. The presented preclinical study was conducted in collaboration with associate professor Girish Kirimanjeswara, Pennsylvania State University, US. Our RAVEN platform rAlready a subscriber Login You have read all your free articles, to continue reading…
Ultimovacs has announced continuing positive efficacy data in its ongoing US-based phase I clinical trial, UV1-103. The study evaluates the company's universal cancer vaccine, UV1, in combination with the anti-PD-1 checkpoint inhibitor pembrolizumab, as first-line treatment in advanced non-resectAlready a subscriber Login You have read all your free articles, to…
The company has announced the completion of the patient enrollment in the company’s phase 3 clinical study SPARKLE with the lead candidate drug Orviglance. “We are very pleased to have reached our enrollment target of 80 patients in the SPARKLE study within our recently updated timelines. ThiAlready a subscriber Login…
Targovax has entered into a clinical trial collaboration agreement with Oslo University Hospital (OUS) to run a phase 1/2 study testing polyvalent mutant RAS vaccine TG01 in multiple myeloma (MM) following standard of care (SoC) therapy. Targovax was recently awarded two research grants from InnoAlready a subscriber Login You have…
